BIOMAT Database Logo BIOMAT Database Logo

Radiation potentiating effect of ethyl bis(2,2-dimethyl-1-aziridinyl) phosphinate (AB-163). 1979

G L Wampler, and J A Wassum, and R Belgrad

UI MeSH Term Description Entries
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D011867 Radioisotope Teletherapy A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit. Teleradioisotope Therapy,Teletherapy, Radioisotope,Therapy, Teleradioisotope
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D005260 Female Females

Related Publications

G L Wampler, and J A Wassum, and R Belgrad
A pilot study with ethyl bis (2,2-dimethyl-1-aziridinyl) phosphinate (AB-163) and radiation therapy.
July 1982, International journal of radiation oncology, biology, physics,
G L Wampler, and J A Wassum, and R Belgrad
Phase I study of ethylbis(2,2-dimethyl-1-aziridinyl) phosphinate (AB-163).
January 1980, Cancer chemotherapy and pharmacology,
G L Wampler, and J A Wassum, and R Belgrad
Synthesis and testing of quinone-based bis(2,2-dimethyl-1-aziridinyl)phosphinyl carbamates as radiation-potentiating antitumor agents.
June 1988, Journal of medicinal chemistry,
G L Wampler, and J A Wassum, and R Belgrad
Laboratory and clinical evaluation of the radiation-potentiating activity of ethyl-N-bis (2,2-dimethylethylamidinophosphoro) carbamate (AB-132).
January 1975, Journal of medicine,
G L Wampler, and J A Wassum, and R Belgrad
Studies on the chemistry, antitumor activity, and pharmacology of ethyl di-(2,2-dimethyl)ethylenamido phosphate (AB-163).
January 1969, Journal of surgical oncology,
G L Wampler, and J A Wassum, and R Belgrad
Dimethyl 2,2-bis-(2-cyano-ethyl)malonate.
April 2008, Acta crystallographica. Section E, Structure reports online,
G L Wampler, and J A Wassum, and R Belgrad
Initial clinical study of tris(2,2-dimethyl-1-aziridinyl)phosphine oxide (TEPA-132).
June 1972, Cancer chemotherapy reports,
G L Wampler, and J A Wassum, and R Belgrad
Synthesis of new bis(1-aziridinyl) phosphinate alkylating agents containing O-phenyl N-phenylcarbamate side chains.
April 1973, Journal of medicinal chemistry,
G L Wampler, and J A Wassum, and R Belgrad
Bis(1-aziridinyl)morpholinophosphine sulphide.
January 1975, IARC monographs on the evaluation of the carcinogenic risk of chemicals to man,
G L Wampler, and J A Wassum, and R Belgrad
SYNTHESIS OF POTENTIAL DUAL ANTAGONISTS. 3. RING-SUBSTITUTED ETHYL (BIS(1-AZIRIDINYL)PHOSPHINYL)CARBAMATES.
February 1965, Journal of pharmaceutical sciences,
Copied contents to your clipboard!